Literature DB >> 14714442

Prospects for antiviral therapy.

P Leyssen1, N Charlier, J Paeshuyse, E De Clercq, J Neyts.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14714442     DOI: 10.1016/s0065-3527(03)61014-6

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN: 0065-3527            Impact factor:   9.937


× No keyword cloud information.
  7 in total

1.  Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers.

Authors:  Richard M Kinney; Claire Y-H Huang; Becky C Rose; Andrew D Kroeker; Theo W Dreher; Patrick L Iversen; David A Stein
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  Eco-friendly reduced graphene oxide for the determination of mycophenolate mofetil in pharmaceutical formulations.

Authors:  Prashanth S Narayan; Nagappa L Teradal; Seetharamappa Jaldappagari; Ashis K Satpati
Journal:  J Pharm Anal       Date:  2017-12-08

Review 3.  Antivirals and antiviral strategies.

Authors:  Erik De Clercq
Journal:  Nat Rev Microbiol       Date:  2004-09       Impact factor: 60.633

4.  A short treatment of cells with the lanthanide ions La3+, Ce3+, Pr3+ or Nd3+ changes the cellular chemistry into a state in which RNA replication of flaviviruses is specifically blocked without interference with host-cell multiplication.

Authors:  Gerd Wengler; Gisela Wengler; Andreas Koschinski
Journal:  J Gen Virol       Date:  2007-11       Impact factor: 3.891

5.  Plaque assay for human coronavirus NL63 using human colon carcinoma cells.

Authors:  Petra Herzog; Christian Drosten; Marcel A Müller
Journal:  Virol J       Date:  2008-11-12       Impact factor: 4.099

Review 6.  Targeting host factors to treat West Nile and dengue viral infections.

Authors:  Manoj N Krishnan; Mariano A Garcia-Blanco
Journal:  Viruses       Date:  2014-02-10       Impact factor: 5.048

Review 7.  Status presens of antiviral drugs and strategies: Part II: RNA VIRUSES (EXCEPT RETROVIRUSES).

Authors:  Erik De Clercq
Journal:  Adv Antivir Drug Des       Date:  2007-09-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.